Sarepta Therapeutics (SRPT) Gross Margin (QoQ) (2017 - 2026)

Sarepta Therapeutics (SRPT) Gross Margin (QoQ) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,132.22 Bn 67,131.94 Bn -
2 Nanobiotix 1,910.87 Bn 1,910.81 Bn -
3 Akari Therapeutics 989.71 Bn 989.71 Bn -
4 BeOne Medicines 471.60 Bn 466.80 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.71 Bn 114.46 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.83 Bn 61.07 Bn 3.31 Bn
7 Belite Bio 62.74 Bn 62.74 Bn -
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.33 Bn 34.32 Bn 959.66 Mn
10 Sarepta Therapeutics 1.71 Bn 1.30 Bn 622.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7,513.00
Dec 31, 2025 -5,226.00
Sep 30, 2025 -1,279.00
Jun 30, 2025 7,821.00
Mar 31, 2025 -8,308.00
Dec 31, 2024 -47.00
Sep 30, 2024 -735.00
Jun 30, 2024 -5.00
Mar 31, 2024 -813.00
Dec 31, 2023 787.00
Sep 30, 2023 109.00
Jun 30, 2023 206.00
Mar 31, 2023 -1,157.00
Dec 31, 2022 1,379.00
Sep 30, 2022 54.00
Jun 30, 2022 -124.00
Mar 31, 2022 111.00
Dec 31, 2021 8,646.00
Sep 30, 2021 -9,233.00
Jun 30, 2021 332.00